生物
粒体自噬
线粒体
代谢组
帕金
细胞生物学
脂质代谢
自噬
品脱1
程序性细胞死亡
脱铁酮
生物化学
去铁胺
细胞凋亡
代谢物
内科学
帕金森病
医学
疾病
作者
Maeve Long,Álvaro Sánchez-Martínez,Marianna Longo,Fumi Suomi,Hans Stenlund,Annika Johansson,Homa Ehsan,Veijo T. Salo,Lambert Montava‐Garriga,Seyedehshima Naddafi,Elina Ikonen,Ian G. Ganley,Alexander J. Whitworth,Thomas G. McWilliams
标识
DOI:10.15252/embj.2021109390
摘要
Mitophagy removes defective mitochondria via lysosomal elimination. Increased mitophagy coincides with metabolic reprogramming, yet it remains unknown whether mitophagy is a cause or consequence of such state changes. The signalling pathways that integrate with mitophagy to sustain cell and tissue integrity also remain poorly defined. We performed temporal metabolomics on mammalian cells treated with deferiprone, a therapeutic iron chelator that stimulates PINK1/PARKIN-independent mitophagy. Iron depletion profoundly rewired the metabolome, hallmarked by remodelling of lipid metabolism within minutes of treatment. DGAT1-dependent lipid droplet biosynthesis occurred several hours before mitochondrial clearance, with lipid droplets bordering mitochondria upon iron chelation. We demonstrate that DGAT1 inhibition restricts mitophagy in vitro, with impaired lysosomal homeostasis and cell viability. Importantly, genetic depletion of DGAT1 in vivo significantly impaired neuronal mitophagy and locomotor function in Drosophila. Our data define iron depletion as a potent signal that rapidly reshapes metabolism and establishes an unexpected synergy between lipid homeostasis and mitophagy that safeguards cell and tissue integrity.
科研通智能强力驱动
Strongly Powered by AbleSci AI